Get started
AlenCiken

Enrolls Initial Patients for First-in-Human CoreoGraft Study

AlenCiken  
NASDAQ:HJLI   None
Trend Analysis Chart Patterns Fundamental Analysis
1
0
trendanalysis chartpattern fundamental
Hancock Jaffe Enrolls Initial Patients for First-in-Human CoreoGraft Study

Interim results for patients in the CoreoGraft study, which will take place at Italian Hospital Asuncion in Paraguay, will be available 30 days, 90 days, 180 days, and 365 days post-surgery.

finance.yahoo.com/ne...ients-150000419.html
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.